Cargando…
Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade
SIMPLE SUMMARY: To summarize the main discoveries made over the past few years to treat metastatic clear cell renal cell carcinoma, including different generations of anti-VEGF TKIs and immune checkpoint inhibitors (ICI), and provide an overview of the future developments to come in this field. We d...
Autores principales: | Larroquette, Mathieu, Lefort, Félix, Heraudet, Luc, Bernhard, Jean-Christophe, Ravaud, Alain, Domblides, Charlotte, Gross-Goupil, Marine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777357/ https://www.ncbi.nlm.nih.gov/pubmed/36551715 http://dx.doi.org/10.3390/cancers14246230 |
Ejemplares similares
-
Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?
por: Granet-Vaissiere, Estelle, et al.
Publicado: (2023) -
Adaptation of multidisciplinary meeting decisions in a medical oncology department during the COVID epidemic in a less affected region of France: a prospective analysis from Bordeaux University Hospital
por: Heraudet, Luc, et al.
Publicado: (2020) -
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
por: Iaxx, Romain, et al.
Publicado: (2022) -
Management of Immune Checkpoint Inhibitor Toxicities
por: Durrechou, Quentin, et al.
Publicado: (2020) -
Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study
por: Heraudet, Luc, et al.
Publicado: (2022)